Clinical Trial Update: Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating tesetaxel with capecitabine and cisplatin in advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• tesetaxel (tesetaxel)

Snippet

Sponsor: Genta Incorporated | Conditions: Gastric Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN